FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Collier Alan Brian 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CEO
(Last)          (First)          (Middle)

6320 CANOGA AVENUE, 15TH FLOOR 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/28/2019
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/28/2019     P    30000   A $0.01   23505597   D    
Common Stock   5/28/2019     P    20000   A $0.01   23525597   D    
Common Stock   5/28/2019     P    50000   A $0.01   23575597   D    
Common Stock   5/28/2019     P    50000   A $0.0105   23625597   D    
Common Stock   5/28/2019     P    25500   A $0.0105   23651097   D    
Common Stock   5/28/2019     P    10000   A $0.0104   23661097   D    
Common Stock   5/28/2019     P    20000   A $0.0105   23681097   D    
Common Stock   5/28/2019     P    50000   A $0.0115   23731097   D    
Common Stock   5/28/2019     P    44038   A $0.011   23775135   D    
Common Stock   5/28/2019     P    5962   A $0.0114   23781097   D    
Common Stock   5/28/2019     P    5000   A $0.0109   23786097   D    
Common Stock   5/29/2019     P    50000   A $0.01   23836097   D    
Common Stock   5/29/2019     P    30000   A $0.0104   23866097   D    
Common Stock   5/29/2019     P    20000   A $0.0108   23886097   D    
Common Stock   5/29/2019     P    10000   A $0.0106   23896097   D    
Common Stock   5/29/2019     P    10000   A $0.0108   23906097   D    
Common Stock   5/29/2019     P    5000   A $0.0106   23911097   D    
Common Stock   5/29/2019     P    5000   A $0.0108   23916097   D    
Common Stock   5/29/2019     P    5000   A $0.0108   23921097   D    
Common Stock   5/29/2019     P    20000   A $0.0103   23941097   D    
Common Stock   5/29/2019     P    5000   A $0.0104   23946097   D    
Common Stock   5/29/2019     P    5000   A $0.012   23951097   D    
Common Stock   5/29/2019     P    5000   A $0.0108   23956097   D    
Common Stock   5/29/2019     P    5000   A $0.0114   23961097   D    
Common Stock   5/29/2019     P    5000   A $0.0119   23966097   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Collier Alan Brian
6320 CANOGA AVENUE
15TH FLOOR
WOODLAND HILLS, CA 91367

CEO

Signatures
Alan Brian Collier 5/30/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.